News


SRI biosciences wins $100 million for radiation research

 

One hundred million dollars over five years. That's how much the SRI International biosciences division is being awarded as part of a contract to research and develop products to address the effects of radiation exposure.

The multi-year contract was awarded by the National Institute of Allergy and Infectious Disease, part of the National Institutes of Health.

The principal investigator for the contract will be Polly Chang, senior director of molecular and genetic toxicology at SRI Biosciences. The award will support work related to developing medical "countermeasures" to address the effects of radiation and nuclear exposure.

SRI International is based in Menlo Park.

Kate Bradshaw

Comments

Sorry, but further commenting on this topic has been closed.

Ice cream shop opens at Stanford Shopping Center
By Elena Kadvany | 1 comment | 5,123 views

The Last Straw
By Laura Stec | 5 comments | 2,357 views

Couples: Do you Really Agree or are you Afraid of not Agreeing?
By Chandrama Anderson | 0 comments | 997 views

Trying to enjoy the routines again
By Cheryl Bac | 0 comments | 500 views

 

2018 guide to summer camps

Looking for something for the kids to do this summer, learn something new and have fun? The 2018 Summer Camp Guide features local camps for all ages and interests.

Find Camps Here